Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Megan-Rose G.
Mexico
USD 100 /hr
Pharmacist with a PhD in addiction-related molecular neuroscience and translational drug discovery.
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Medical Writing,
General Proofreading & Editing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Healthcare Consulting,
Scientific and Technical Consulting
Work Experience
Locum Pharmacist
locatealocum
August 2020 - Present ![]()
Clinical Research Assistant
NHS (UK)
January 2025 - January 2026
Education
Wellcome Trust DTP - Molecular Pharmacology and Drug Discovery (Biodiscovery Institute)
University of Nottingham
September 2021 - September 2025 ![]()
MPharm Masters of Pharmacy
University of Nottingham
September 2015 - June 2019 ![]()
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Kate Lacey, Megan R. Greener, Tangkam R. Marak, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Stewart G. Martin, Sarah J. Storr (2024). Protein Tyrosine Kinase 7 (PTK7) in Breast Cancer: A Retrospective Analysis of Tumour Expression and Association with Clinical Outcome . Cancers.
Kate Lacey, Megan R. Greener, Tangkam R. Marak, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Stewart G. Martin, Sarah J. Storr (2024). Protein Tyrosine Kinase 7 (PTK7) in Breast Cancer: A Retrospective Analysis of Tumour Expression and Association with Clinical Outcome . Cancers.
Megan-Rose Greener, Behnaz Saidy, Richa Vasan, Rosie Durant, Adelynn Immanuel, Andrew R. Green, Emad Rakha, Ian Ellis, Graham Ball, Stewart G. Martin, et al. (2023). Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways . Scientific Reports.
Megan R. Greener, Sarah J. Storr (2023). Conflicting theories on addiction aetiology and the strengths and limitations of substance use disorder disease modelling . Frontiers in Molecular Neuroscience.
Megan R. Greener, Sarah J. Storr (2022). Exploring the Role of DARPP-32 in Addiction: A Review of the Current Limitations of Addiction Treatment Pathways and the Role of DARPP-32 to Improve Them . NeuroSci.
CONFERENCE ABSTRACT
Megan Greener (2023). A TRANSCRIPTOMIC ANALYSIS OF DOPAMINE- AND CAMP-REGULATED PHOSPHOPROTEIN, MR 32 KDA (DARPP-32) SIGNALLING PATHWAYS IN THE PRESENCE OF DRUGS OF ABUSE . IBRO Neuroscience Reports.